|Articles|February 1, 2011
- BioPharm International-02-01-2011
- Volume 24
- Issue 2
BioPharm International, February 2011 Issue (PDF)
The Quality Product Steward Model
Advertisement
Articles in this issue
almost 15 years ago
The Quality Product Steward Model: The Genentech Approachalmost 15 years ago
An Economic Comparison of Three Cell Culture Techniquesalmost 15 years ago
The Powerful Lesson of the GSK–Whistleblower Casealmost 15 years ago
Driving your Product to Profitability with Project Management at the Wheelalmost 15 years ago
Trends Toward Standardizationalmost 15 years ago
Congress to Scrutinize FDA Rules, Research Policiesalmost 15 years ago
What a Piece of Work is PharmaNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
3
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
4
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
5
